Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease

被引：0
|
作者：
Saely, Christoph [1 ,2 ,3 ]
Vonbank, Alexander [1 ,2 ]
Lins, Christina [1 ]
Zanolin, Daniela [1 ]
Leiherer, Andreas [1 ,3 ]
Schuler, Alexandra [1 ,2 ]
Ebner, Karl-Martin [1 ,2 ]
Rein, Philipp [1 ,2 ]
Schwerzler, Peter [1 ,2 ]
Mader, Arthur [1 ,2 ]
Muendlein, Axel [1 ]
Drexel, Heinz [1 ,3 ,4 ]
机构：
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2017年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P23
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [31] Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Filippatos, Gerasimos
    Anker, Stefan D.
    Pitt, Bertram
    McGuire, Darren K.
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Jankowska, Ewa A.
    Michos, Erin D.
    Farmakis, Dimitrios
    Farjat, Alfredo E.
    Kolkhof, Peter
    Scalise, Andrea
    Joseph, Amer
    Bakris, George L.
    Agarwal, Rajiv
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 9 (01) : 85 - 93
  • [32] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis M.
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2020, 142 (24) : E470 - E470
  • [33] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [34] Response to cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus and chronic kidney disease
    Angel Salinero-Fort, Miguel
    San Andres-Rebollo, Javier
    Gomez-Campelo, Paloma
    Lopez de Andres, Ana
    Jimenez-Garcia, Rodrigo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (03) : 647 - 647
  • [35] Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"
    Koh, Kwang Kon
    CIRCULATION, 2018, 138 (08) : 846 - 847
  • [36] CHARACTERISING THE RELATIVE IMPACT OF ESTABLISHED CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE ON QUALITY OF LIFE IN DIABETES PATIENTS
    Kelly, M.
    Higgins, V
    Leith, A.
    Ellams, A.
    Piercy, J.
    VALUE IN HEALTH, 2017, 20 (09) : A484 - A484
  • [37] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [38] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [39] Type 2 Diabetes and Chronic Kidney Disease as Predictors of Cardiovascular Events in Patients with Coronary Artery Disease
    Plattner, Thomas
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
  • [40] Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial
    Branch, Mary
    German, Charles
    Bertoni, Alain
    Yeboah, Joseph
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (07) : 468 - 472
12345